Thursday, March 21, 2019

Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

Concomitant use of benzodiazepine drugs common amongst AD patients

Concomitant use of benzodiazepine drugs common amongst AD patients

The most commonly concomitant use amongst AD patients was benzodiazepine drugs and a weak opioid – where one in five people with Alzheimer’s disease...
According to NYU School of Medicine, men and women identifying as lesbian, gay, or bisexual are at a higher risk of opioid misuse compared with those who identify as heterosexual.

Levels of opioid misuse may be dependent on sexual orientation

According to NYU School of Medicine, men and women identifying as lesbian, gay, or bisexual are at a higher risk of opioid misuse compared...
Medical benefits of cannabis may be less effective than the liverwort plant

Medical benefits of cannabis may be less effective than the liverwort plant

For the first time researchers have found that the substance found in the liverwort plant could have the medical benefits of cannabis, perhaps even...
5th Precision Medicine and Biomarkers Leaders Summit: Europe

5th Precision Medicine and Biomarkers Leaders Summit: Europe

Health Europa listened to InnVentis CEO Thomas Wilckens discuss some of the diagnostic and data challenges involved in precision medicine. The 5th Precision Medicine and...
Michael Lisanti and antibiotics: the next cancer revolution

Michael Lisanti and antibiotics: the next cancer revolution

Speaking to Health Europa, Professor Michael Lisanti, MD-PhD, FRSA discusses the potential role of antibiotics in preventing the recurrence of cancer. How would you cure...
From highly priced medicines to Medicines That Matter

From highly priced medicines to Medicines That Matter

Highly priced medicines represent a significant public health challenge. Global health advocate Ella Weggen shares how Wemos is responding through its dedicated project Medicines...
BioBlocks, Inc. are changing the game of drug discovery

BioBlocks, Inc.: Transforming the process of lead discovery

BioBlocks CEO Dr Peter Pallai discusses how BioBlocks is making drug discovery more straightforward, faster and more economical using data-driven approaches. BioBlocks is a medicinal...
Open Targets – transforming drug discovery

Open Targets – transforming drug discovery

Health Europa talks with Open Targets who discuss how the platform works to systematically identify and prioritise drug discovery to develop safe and effective...
Cocaine contaminant, levamisole, may cause brain damage

Cocaine contaminant, levamisole, may cause brain damage

Individuals who regularly take the cocaine contaminant, levamisole, demonstrate impaired cognitive performance & a thinned prefrontal cortex. Recent findings from the University of Zurich, Switzerland, indicate...
Prudenta: an electronic solution for local literature monitoring in pharmacovigilance

Prudenta: an electronic solution for local literature monitoring in pharmacovigilance

Dr Polina Dombure, the managing director of Inpharmatis, introduces Prudenta, an innovative pharmacovigilance solution set to transform local literature monitoring. The costly, time-consuming and error-prone...
Assessing the environmental risk of pharmaceuticals

Assessing the environmental risk of pharmaceuticals

AstraZeneca’s Jason Snape, outlined his company’s approach to the environmental risk assessment of human medicinal products and what more needs to be in place...
Challenges and opportunities in cancer drug development

Challenges and opportunities in cancer drug development

Managing director Professor Heinz Zwierzina of the Cancer Drug Development Forum talks Health Europa through the challenges in the search for new cancer drugs. The...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest